About
Wave Life Sciences develops RNA-targeting therapeutics using RNA editing and RNA interference technologies to treat rare and common genetic diseases, including conditions such as Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington’s disease, and obesity.
Explore Wave Life Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.